Literature DB >> 8643674

Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.

G J Clark1, J K Drugan, R S Terrell, C Bradham, C J Der, R M Bell, S Campbell.   

Abstract

A key event in Ras-mediated signal transduction and transformation involves Ras interaction with its downstream effector targets. Although substantial evidence has established that the Raf-1 serine/threonine kinase is a critical effector of Ras function, there is increasing evidence that Ras function is mediated through interaction with multiple effectors to trigger Raf-independent signaling pathways. In addition to the two Ras GTPase activating proteins (GAPs; p120- and NF1-GAP), other candidate effectors include activators of the Ras-related Ral proteins (RalGDS and RGL) and phosphatidylinositol 3-kinase. Interaction between Ras and its effectors requires an intact Ras effector domain and involves preferential recognition of active Ras-GTP. Surprisingly, these functionally diverse effectors lack significant sequence homology and no consensus Ras binding sequence has been described. We have now identified a consensus Ras binding sequence shared among a subset of Ras effectors. We have also shown that peptides containing this sequence from Raf-1 (RKTFLKLA) and NF1-GAP (RRFFLDIA) block NF1-GAP stimulation of Ras GTPase activity and Ras-mediated activation of mitogen-activated protein kinases. In summary, the identification of a consensus Ras-GTP binding sequence establishes a structural basis for the ability of diverse effector proteins to interact with Ras-GTP. Furthermore, our demonstration that peptides that contain Ras-GTP binding sequences can block Ras function provides a step toward the development of anti-Ras agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643674      PMCID: PMC39983          DOI: 10.1073/pnas.93.4.1577

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

Review 2.  Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.

Authors:  J B Gibbs; A Oliff; N E Kohl
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

Review 3.  The effector interactions of p21ras.

Authors:  M S Marshall
Journal:  Trends Biochem Sci       Date:  1993-07       Impact factor: 13.807

4.  Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation.

Authors:  J K Drugan; R Khosravi-Far; M A White; C J Der; Y J Sung; Y W Hwang; S L Campbell
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

5.  Mammalian Ras interacts directly with the serine/threonine kinase Raf.

Authors:  A B Vojtek; S M Hollenberg; J A Cooper
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

6.  Cooperative interaction of S. pombe proteins required for mating and morphogenesis.

Authors:  E C Chang; M Barr; Y Wang; V Jung; H P Xu; M H Wigler
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

Review 7.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

8.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

9.  A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function.

Authors:  J R Fabian; A B Vojtek; J A Cooper; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras.

Authors:  S Ghosh; W Q Xie; A F Quest; G M Mabrouk; J C Strum; R M Bell
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

View more
  18 in total

1.  The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation.

Authors:  M Daub; J Jöckel; T Quack; C K Weber; F Schmitz; U R Rapp; A Wittinghofer; C Block
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 2.  Targeting Ras with Macromolecules.

Authors:  Dehua Pei; Kuangyu Chen; Hui Liao
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 3.  The RAS-Effector Interaction as a Drug Target.

Authors:  Adam B Keeton; E Alan Salter; Gary A Piazza
Journal:  Cancer Res       Date:  2017-01-06       Impact factor: 12.701

4.  Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways.

Authors:  Aparna Kaul; Jean H Overmeyer; William A Maltese
Journal:  Cell Signal       Date:  2006-11-28       Impact factor: 4.315

5.  Protein binding and signaling properties of RIN1 suggest a unique effector function.

Authors:  L Han; D Wong; A Dhaka; D Afar; M White; W Xie; H Herschman; O Witte; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.

Authors:  H R Mott; J W Carpenter; S Zhong; S Ghosh; R M Bell; S L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins.

Authors:  Mehmet Cetin; William E Evenson; Garrett G Gross; Farzad Jalali-Yazdi; Daniel Krieger; Don Arnold; Terry T Takahashi; Richard W Roberts
Journal:  J Mol Biol       Date:  2016-11-16       Impact factor: 5.469

8.  Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.

Authors:  Steven D Rhodes; Hao Yang; Ruizhi Dong; Keshav Menon; Yongzheng He; Zhaomin Li; Shi Chen; Karl W Staser; Li Jiang; Xiaohua Wu; Xianlin Yang; Xianghong Peng; Khalid S Mohammad; Theresa A Guise; Mingjiang Xu; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

9.  Inhibition of Ras-Effector Interaction by Cyclic Peptides.

Authors:  Xianghong Wu; Punit Upadhyaya; Miguel A Villalona-Calero; Roger Briesewitz; Dehua Pei
Journal:  Medchemcomm       Date:  2013-02-01       Impact factor: 3.597

10.  Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.

Authors:  Elisabeth A Lasater; Waylan K Bessler; Laura E Mead; Whitney E Horn; D Wade Clapp; Simon J Conway; David A Ingram; Fang Li
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.